Evidence map›Paper›PMID 38175227›Full record

ArticleArchives of dermatological research2024

Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population.

Madeline Deike, Jiancong Wang, Ralph Brinks, Stephan Meller, Lennart Ocker, Falk G Bechara, Jörg H W Distler, Xenofon Baraliakos, David Kiefer, Philipp Sewerin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Madeline Deike *Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, 40225, Düsseldorf, Germany.
Jiancong Wang *Institute of Biometry and Epidemiology, The German Diabetes Center, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID http://orcid.org/0000-0001-6284-9702
Ralph BrinksHiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, 40225, Düsseldorf, Germany.ORCID http://orcid.org/0000-0003-0961-6592
Stephan MellerClinic for Dermatology, University Hospital Duesseldorf, Medical Faculty of Heinrich-Heine-University, Duesseldorf, Germany.
Lennart OckerDepartment of Dermatology, Venereology and Allergology, St Josef Hospital, Ruhr-University, Bochum, Germany.
Falk G BecharaDepartment of Dermatology, Venereology and Allergology, St Josef Hospital, Ruhr-University, Bochum, Germany.ORCID http://orcid.org/0000-0003-0418-521X
Jörg H W DistlerHiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, 40225, Düsseldorf, Germany.ORCID http://orcid.org/0000-0001-7408-9333
Xenofon BaraliakosRuhr-Universität Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany.ORCID http://orcid.org/0000-0002-9475-9362
David KieferRuhr-Universität Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany.ORCID http://orcid.org/0000-0003-1602-7649
Philipp SewerinHiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, 40225, Düsseldorf, Germany. Philipp.Sewerin@med.uni-duesseldorf.de.ORCID http://orcid.org/0000-0001-8465-6207

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Information on the population-based incidence of psoriasis vulgaris was limited. This study was to provide a comprehensive understanding of the age-specific and sex-specific incidence of psoriasis vulgaris in Germany. The data were obtained in the context of a morbidity-based risk adjustment by statutory health insurance companies in Germany, comprising information regarding 65 million population. Psoriasis vulgaris diagnoses were made and coded according to the 10th edition of the International Statistical Classification of Diseases and Related Health Problems. Age-specific and sex-specific incidences were calculated using data from 2009 to 2011. There was a rise in the age- and sex-specific incidences of psoriasis vulgaris through midlife, reaching a peak at the age of 60 and subsequently declining for both genders. The peak incidence for men, at 130 cases per 100,000 person-years, slightly exceeded the peak incidence for women of 117 per 100,000 person-years. An increase in the overall incidence rate can also be observed over the course of the three-year period covered by the data. Considerable variations in the age- and sex-specific incidences of psoriasis vulgaris can be seen across the lifespan. Nevertheless, the overall age-standardized incidence for the German population was low compared to other European countries.

Indexed as

InsuranceEuropeFemaleGermanyHumansIncidenceMaleAge-specificAge-standardizedGermanyIncidencePopulation-basedPsoriasis vulgarisSex-specific

Identifiers

PMID38175227
PMCPMC10766663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.